MyAverix Finance
MX · Healthcare
Genomma Lab Internacional S.A.B. de C.V (LABB)
Drug Manufacturers - Specialty & Generic
Genomma Lab Internacional S.A.B. de C.V (LABB) is listed on MX in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LABB
Genomma Lab Internacional S.A.B. de C.V (LABB) — FAQ
What is LABB's P/E ratio?
The price-to-earnings (P/E) ratio for Genomma Lab Internacional S.A.B. de C.V (LABB) is 18.00 (data as of 2026-05-24).
Does Genomma Lab Internacional S.A.B. de C.V pay a dividend?
Dividend yield is not available in the current snapshot for Genomma Lab Internacional S.A.B. de C.V (LABB). Check the MyAverix Finance app for the latest dividend data.
What sector is Genomma Lab Internacional S.A.B. de C.V in?
Genomma Lab Internacional S.A.B. de C.V (LABB) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LABB listed on?
LABB is listed on MX.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.